Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cell Death and Disease is Scopus-indexed (Q1, CiteScore 17.6), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by Springer Nature.
Checked against the index lists dated .
ISSN 2041-4889Verify ISSN ↗
Publisher: Springer Nature
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cellular and Molecular Neuroscience | 6 / 102 | 94th | Q1 |
| Cancer Research | 17 / 233 | 92nd | Q1 |
| Immunology | 19 / 243 | 92nd | Q1 |
| Cell Biology | 25 / 289 | 91st | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q1, CiteScore 17.6.
Cell Death and Disease is Q1 in Cellular and Molecular Neuroscience (rank 6 of 102), Q1 in Cancer Research (rank 17 of 233) and Q1 in Immunology (rank 19 of 243), by CiteScore 2025. It is ranked in 4 subject areas in all.
Cell Death and Disease is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 17.6, which places it in quartile Q1 at the 94th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 3.291, quartile Q1, with an H-index of 202.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$4,990 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cell Death and Disease is published by Springer Nature. Its ISSN is 2041-4889.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Cell Death and Disease has an h-index of 239 and a 2-year mean of 9.15 citations per paper (OpenAlex). Its Scopus CiteScore is 17.6, quartile Q1. On 2-year citations it ranks #9 of 102 Scopus journals in Cellular and Molecular Neuroscience.
Cell Death and Disease published 1,033 papers in 2025; its busiest recent year was 2018 with 1,207. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from China (57.7%), United States (9.9%) and Germany (4.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 187 retracted papers are recorded (15.2 per 1,000 papers). The Problematic Paper Screener flags 6 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.